Navigation Links
Insulin Administration and Nutritional Therapy Requires Standardized Coordination, Says ECRI Institute PSO
Date:11/15/2012

PLYMOUTH MEETING, Pa., Nov. 15, 2012 /PRNewswire-USNewswire/ -- Insulin has consistently been declared a high-alert medication due to the risks associated with its prescribing and dosing. When a nutrition order for a patient is modified, the patient's insulin regimen may inadvertently remain unreviewed or unchanged. ECRI Institute Patient Safety Organization (PSO) has seen both events and research requests pertaining to this issue.

(Logo: http://photos.prnewswire.com/prnh/20110112/DC29081LOGO)

"Because diabetic and non-diabetic patients receiving nutritional therapy and insulin are often managed by more than one practitioner, facilities need to implement a standardized process to ensure coordinated care," states Karen P. Zimmer, MD, MPH, FAAP, medical director, ECRI Institute PSO. "Yet when we further explored this topic, there was minimal literature that discussed best practices and among the hospitals we approached, there was no consensus on how to best go about this. The analysis of aggregated reports continues to reveal gaps that we need to address."

ECRI Institute PSO's recently released Patient Safety E-lert, "It's More Than Counting Carbs, It's Communication and Coordination: Insulin Administration and Nutritional Therapy," highlights this patient safety issue involving patients who are receiving enteral or total parenteral nutrition and insulin. The issue came to light when ECRI Institute PSO analyzed reports submitted by participating healthcare providers. As part of its mission to research the best approaches to improving patient care, ECRI Institute is sharing this special E-lert with the healthcare community.

"Reports submitted to Patient Safety Organizations can surface less-known or undetected risks, like those highlighted in this report," states Barbara Rebold, RN, MS, CPHQ, director of operations, ECRI Institute PSO. "We want to share the potential risk we are seeing in our PSO reports and recommend ways to prevent or mitigate that risk."

For questions about this topic, or for information about ECRI Institute PSO, contact ECRI Institute by telephone at (610) 825-6000, ext. 5558; by e-mail at pso@ecri.org; by fax at (610) 834-1275, or by mail at 5200 Butler Pike, Plymouth Meeting, PA 19462-1298, USA. To sign up for the PSO Monthly Brief, a free eNewsletter comprised of a brief article each month to help keep readers informed about Patient Safety Organizations, go to www.ecri.org/psobrief.

About ECRI Institute
For nearly 45 years, ECRI Institute's work in patient safety, adverse event reporting and analysis, and development of recommendations has improved patient care at hospitals and other providers around the world. The ECRI Institute Patient Safety Organization is a component of ECRI Institute, a nonprofit 501(c)(3) organization dedicated to improving the safety, quality, and cost-effectiveness of patient care. ECRI Institute has a long history of investigating adverse events and publishing authoritative risk reduction strategies. ECRI Institute is designated as an Evidence-based Practice Center by the U.S. Agency for Healthcare Research and Quality. ECRI Institute developed and implements the Pennsylvania Patient Safety Reporting System, a mandatory error and near-miss reporting program for Pennsylvania hospitals and other healthcare facilities, under contract to the Pennsylvania Patient Safety Authority, winner of the 2006 John M. Eisenberg Award. For more information, visit www.ecri.org. Find ECRI Institute on Facebook (www.facebook.com/ECRIInstitute) and Twitter (www.twitter.com/ECRI_Institute).


'/>"/>
SOURCE ECRI Institute
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Diabetes Care Devices Market to 2018 - Integrated Insulin Pumps with Continuous Glucose Monitoring Technology to Add a New Dimension to Diabetes Management
2. Insulin degludec and insulin degludec/insulin aspart receive positive vote for approval from FDA Advisory Committee
3. Lilly to Expand Indianapolis Insulin Manufacturing Operations
4. Global Insulin Market Expected to Reach USD 32,346.7 Million in 2018, with China Alone Accounting for 10.2%: Transparency Market Research
5. Biodel Announces Phase 2 Clinical Trial Initiation Of Ultra-Rapid-Acting Insulin Candidate BIOD-123
6. montméd, Inc. to Market FRiO Insulin Wallets in 20 countries of Middle East and North Africa
7. In Pilot Study, a Peptide Controls Blood Sugar in People with Congenital Hyperinsulinism
8. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
9. FDA clears Accu-Chek Combo system - Roches new interactive insulin pump system for people with diabetes
10. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
11. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... , Sept. 7, 2017  For nearly two decades, New Life ... the Assisted Reproduction Insurance industry. Today, New Life Agency announces a powerful ... ... (PRNewsfoto/PharmaCareCard) ... http://pharmacarecard.com/ ...
(Date:9/6/2017)... 2017  Robert G. Szewc, M.D., is recognized by ... recognition of his contributions to the Medical field.      ... at the practice of Kidney and Hypertension Specialists, which ... hypertension solutions. He has worked in this position since ... as well as expertise in kidneys, hypertension, chronic disease ...
(Date:9/5/2017)... Sept. 5, 2017 Sapheneia and Scannerside received ... Scannerside DoseCheck is a third-party Vendor neutral CT product ... and allows compliance with current MITA standards. ... 29 DoseCheck solution is specifically designed to provide CT ... potential radiation doses over a predefined threshold. Scannerside Dose ...
Breaking Medicine Technology:
(Date:9/23/2017)... California (PRWEB) , ... September 23, 2017 , ... ... discusses the behavioral approach to fighting obesity of Robert Kushner, director of Chicago’s ... to weight loss and promoting healthier habits, the article notes that the center ...
(Date:9/22/2017)... , ... September 22, 2017 , ... MEDIA OPPORTUNITY: , ... rally to interview citizens on why they are rallying against Mayo Clinic. Specifically, media ... this effort against Dr. Noseworthy’s (CEO) decision to close the Albert Lea hospital. , ...
(Date:9/22/2017)... TX (PRWEB) , ... September 22, 2017 , ... Fenwick ... to strengthen the communities they serve as part of the nationally recognized ‘Agents of ... working closely with nonprofit organizations and community leaders to seek out those who most ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... in Pennsylvania, is pleased to offer in-home and online newborn sleep consultations ... deprivation has on the body,” says company owner Courtney Zentz, a pediatric sleep ...
(Date:9/22/2017)... ... September 22, 2017 , ... Pullano Law Offices, a Chicago personal ... has been selected to serve as President of the North Suburban Bar Association ... and Award Dinner hosted by the NSBA at the North Shore Country Club in ...
Breaking Medicine News(10 mins):